Amplius Wealth Advisors’s Vivani Medical VANI Stock Holding History

Amplius Wealth Advisors’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-333	Closed	-$1K	–	866
2021 Q4	$1K	Buy	+333	New	+$2.44K	﹤0.01%	912

Other funds holding VANI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Amplius Wealth Advisors's VANI Position: Q1 2022 in Review

Amplius Wealth Advisors sold out of Vivani Medical (VANI) in Q1 2022, closing a stake of 333 shares — an estimated $1K sold.

Amplius Wealth Advisors first reported a position in VANI in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 28 funds tracked by Wall St. Rank hold VANI as of Q1 2022.

Amplius Wealth Advisors reported no remaining Vivani Medical position as of Q1 2022 after selling out during the quarter.
Amplius Wealth Advisors sold 333 Vivani Medical shares in Q1 2022, an estimated $1K.
Amplius Wealth Advisors first reported a position in Vivani Medical in Q4 2021 and held it in 1 quarter.
Amplius Wealth Advisors's Vivani Medical position peaked at $1K in Q4 2021.
28 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2022.

Based on Amplius Wealth Advisors's 13F filing for Q1 2022, filed 9 May 2022.